Bafna Pharmaceuticals' public issue of 64,00,000 equity shares of Rs 10 each at a price of Rs 40  per equity share (including share premium of Rs 30 per equity share) for cash aggregating Rs 25.60 crores will open for subscription on May 27, 2008 and will close on May 30, 2008.

The issue will constitute 40.05% of the post issue paid-up capital of the company. The issue price is 4 times of the face value. The shares are proposed to be listed on the BSE.

Objects of the issue are as follows:

• Brand building in domestic markets Rs 10.44 crore.
• Part payment of loan from SBI Rs 4 crore.
• Brand building in international markets Rs 3.03 crore.
• Setting up R&D facilities Rs 3 crore.
• MHRA Accrediation Rs 1.08 crore.
• Public Issue expenses Rs 2.05 crore.

Cameo Corporate Services is the Registrar to the Issue.

Ashika Capital and Keynote Corporate Services are the Lead Managers to the Issue.